R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13-Reference-Cited by-同舟云学术

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13

Published:2023-11 Issue:11 Volume:12 Page:
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:J. Comp. Eff. Res.

Author:

Bray Benjamin D¹²,Ramagopalan Sreeram V¹³

Affiliation:

1. Lane Clark & Peacock, London, W1U 1DQ, UK

2. Department of Population Health Sciences, King's College London, SE1 1UL, UK

3. Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK

Abstract

In this latest update we highlight a report from the European Medicines Agency on their use of real-world evidence (RWE) in decision making, RWE reporting guidance from the Canadian Agency for Drugs and Technologies in Health and highlight some new data demonstrating the value medicines for spinal muscular atrophy have brought patients.

Publisher

Becaris Publishing Limited

Subject

Health Policy

Link

https://becarispublishing.com/doi/pdf/10.57264/cer-2023-0141

Reference12 articles.

1. European Medicines Agency. Use of real-world evidence in regulatory decision making – EMA publishes review its studies. https://www.ema.europa.eu/en/news/use-real-world-evidence-regulatory-decision-making-ema-publishes-review-its-studies (2023).

2. Performing studies using the UK Clinical Practice Research Datalink: to link or not to link?;McDonald L;Eur. J. Epidemiol.,2018

3. Real-world data really matter;McDonald L;CMAJ.,2017

4. Lack of data sharing in observational studies;McDonald L;BMJ.,2017

5. NICE real-world evidence framework. https://www.nice.org.uk/corporate/ecd9/chapter/overview (2022).